Behavioral and genetic markers of susceptibility to escalate fentanyl intake
2024

Behavioral and genetic markers of fentanyl intake escalation

Sample size: 63 publication 10 minutes Evidence: moderate

Author Information

Author(s): Keady Jack, Charnigo Richard, Shaykin Jakob D., Prantzalos Emily, Xia Mengfan, Denehy Emily, Bumgardner Cody, Miller Justin, Ortinski Pavel, Bardo Michael T., Turner Jill R.

Primary Institution: University of Kentucky

Hypothesis

Individual differences in motivation for non-drug rewards influence the likelihood and extent of subsequent fentanyl use.

Conclusion

The study found that sucrose breakpoints did not predict fentanyl acquisition or change during escalation, but certain gene networks were linked to escalated fentanyl intake.

Supporting Evidence

  • Sucrose breakpoints did not predict fentanyl acquisition.
  • Gene networks associated with fentanyl escalation were identified.
  • Transcription factors EZH2 and JARID2 were linked to escalated fentanyl intake.

Takeaway

Rats that liked sugar didn't necessarily take more fentanyl later, but some genes were linked to those that did take more fentanyl.

Methodology

Male and female Sprague-Dawley rats were trained in a sucrose reinforcement task and then underwent fentanyl self-administration sessions, followed by RNA sequencing of brain tissue.

Potential Biases

Potential biases may arise from the specific selection of behavioral phenotypes and the limited sample size for certain analyses.

Limitations

The study's findings may not generalize beyond the specific rat model used and the conditions of the experiments.

Participant Demographics

Male and female Sprague-Dawley rats, n=63.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1101/2024.12.06.627259

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication